Mehmet Akce, MD

Associate Professor, Division of Hematology and Oncology, Department of Medicine, O’Neal Comprehensive Cancer Center, The University of Alabama at Birmingham

[Mehmet Akce, MD @MehmetAkce2]

Long live the Republic!

[Mehmet Akce, MD @MehmetAkce2]

@GiOncNow @BasselElRayesMD @ONealCancerUAB Forever grateful for your mentorship, Dr. El-Rayes.

[GI Oncology Now @GiOncNow]

⭐ In an exclusive interview with GI Oncology Now, @BasselElRayesMD of @ONealCancerUAB reflects on his career in translational research and his efforts to expand clinical trial infrastructure and foster collaboration: https://t.co/gSa96gf0Ry

[Midhun Malla @MallaMidhun]

Frontline and beyond frontline therapeutic options in pancreatic ductal adenocarcinoma. @BasselElRayesMD provides his expert insights on targeted therapeutic approaches with a comprehensive review!! @JBartRose @ONealCancerUAB @MehmetAkce2

[Bassel El-Rayes, MD @BasselElRayesMD]

Awesome presentation on rectal cancer management by @MallaMidhun at our GI symposium

[Mehmet Akce, MD @MehmetAkce2]

Forever grateful to Mustafa Kemal Ataturk!

[Midhun Malla @MallaMidhun]

Excitement of travel to ASCO got tripled after I ran into @MehmetAkce2 and @GrantWilliamsMD Talking science en route to Chicago from Alabama @BasselElRayesMD #UAB #onealcomprehensivecancercenter

[Mehmet Akce, MD @MehmetAkce2]

@ozlembilen2 @EmoryDeptofMed Congratulations. Very well deserved!

[Ekrem İmamoğlu (International) @imamoglu_int]

Last night, Istanbul hosted a spectacular celebration in honor of our Republic’s 100th anniversary 🇹🇷🇹🇷🇹🇷

[Mehmet Akce, MD @MehmetAkce2]

Long live the Republic of Türkiye!

[Mehmet Akce, MD @MehmetAkce2]

@MallaMidhun @BasselElRayesMD @ONealCancerUAB @UABHemOncFellow Excellent talks by UAB GI Med Onc team members and excellent conference!

[Bassel El-Rayes, MD @BasselElRayesMD]

Looking forward to a great ONeal Hematology Oncology Review @ONealCancerUAB @UABHemOncFellow

[Mehmet Akce, MD @MehmetAkce2]

@teekayowo @UMGCCC Congratulations Taofeek!

[Academic & Community Cancer Research United @accru__network]

ACCRU GI-2017 explores second line treatment options for patients with HCC Hepatocellular Carcinoma. Learn more. https://t.co/MMxh0KSEal #GI #GISM #GICancer

[Academic & Community Cancer Research United @accru__network]

Learn about the criteria for enrollment in ACCRU study GI-2017, a Phase II study for patients with HCC. https://t.co/TajzC6AWAy #HCC #HCCSM

[Mehmet Akce, MD @MehmetAkce2]

@WinshipAtEmory @LesinskiLab Congratulations Greg. Very well deserved.

[Kemal Kılıçdaroğlu @kilicdarogluk]

Vatanını seven sandığa gelir.

[Kemal Kılıçdaroğlu @kilicdarogluk]

Millet Buluşması #Uşak https://t.co/RcFDZrJd6z

[OncLive SOSS @OncLiveSOSS]

Maya Khalil, MD, of @ONealCancerUAB, discusses key clinical trial updates on the use of nivolumab and ipilimumab with or without chemotherapy in non–small cell lung cancer. #lcsm https://t.co/EFAJyKSldu